References
- O’DonnellDEBertleyJCChauLKWebbKAQualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanismsAm J Respir Crit Care Med19971551091159001298
- O’DonnellDERevillSMWebbKADynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116477077711549531
- BelmanMJBotnickWCShinJWInhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19961539679758630581
- FujimotoKKitaguchiYKandaSUrushihataKHanaokaMKuboKComparison of efficacy of long-acting bronchodilators in emphysema dominant and non-dominant COPDInt J Chron Obstruct Pulmon Dis2011621922721660299
- BattramCCharltonSJCuenoudBIn vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled β2 adrenoceptor agonist with a 24-h duration of actionJ Pharmacol Exp Ther200631776277016434564
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseBethesda (MD)GOLD2017
- BeehKMWestermanJKirstenAMThe 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseasePulm Pharmacol Ther201532535925956072
- MahlerDAD’UrzoABatemanEDConcurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonThorax20126778178822544891
- BertonDCReisMSiqueiraACEffects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPDRespir Med20101041288129620580216
- TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD assessment testRespir Investig2012503439
- GotohYP-ADLJapan Society for Respiratory Care and Rehabilitation, Japanese Respiratory Society, Japanese Association of Rehabilitation Medicine, Japanese Physical Therapy AssociationRespiratory Rehabilitation Manual: Exercise Therapy2nd edTokyoShourinsha2012171
- SasakiENakamuraMKidaKReference values for spirogram and blood gas analysis in Japanese non-smoking healthy adultsJ Jpn Respir Soc200139383399
- NishidaSKambeMSewakeNTakanoMKawaneHPulmonary function in healthy subjects and its prediction–5: pulmonary diffusing capacity in adultsJpn J Clin Pathol197624941947
- BorenHGKoryRCSynerJCThe Veterans Administration Army cooperative study of pulmonary functionAm J Med19664196114
- KitaguchiYFujimotoKKomatsuYHanaokaMHondaTKuboKAdditive efficacy of short-acting bronchodilators on dynamic hyper-inflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilatorsRespir Med201310739440023245993
- FarneHACatesCJLong-acting β2-agonist in addition to tiotropium versus either tiotropium or long-acting β2-agonist alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201510CD00898926490945
- O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
- FujimotoKYoshiikeFYasuoMEffects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPDRespirology200712939917207032
- BeehKMWagnerFKhindriSDrollmannAFEffect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPDCOPD2011834034521793716
- KatoMMakitaHUemuraKBronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: a randomised, double-blind, placebo-controlled trialAllergol Int20105928529320567133
- DecramerMLChapmanKRDahlROnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med2013152453324461613
- GelbAFGutierrezCAWeismanIMNewsomRTaylorCFZamelNSimplified detection of dynamic hyperinflationChest20041261855186015596684